NFκB诱寡氧核酸在治疗呼吸道疾病中的新兴应用和前景
Jessica Katrine Datsyuk1, Keshav Raj Paudel2, Rashi Rajput1
1Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, 2007, Australia.
本综述探讨了使用通过纳米颗粒传递的诱寡氧核酸来治疗慢性呼吸道炎症,准转录因子NFκB. 这种方法旨在克服目前喘和COPD治疗方法的局限性.
科学领域:
- 生物医学工程 生物医学工程
- 分子生物学分子生物学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 喘和COPD等慢性呼吸道疾病对社会造成重大负担.
- 目前的治疗依赖于每日药物治疗,有效性有限.
- 了解慢性炎症,特别是转录因子NFκB的作用,至关重要.
研究的目的:
- 审查诱寡氧核酸阻断NFκB激活的潜力.
- 探索基于纳米粒子的药物输送系统,以提高治疗疗效.
- 研究用于治疗慢性呼吸道炎症的联合应用.
主要方法:
- 作为NFκB抑制剂的诱寡氧核酸.
- 纳米粒子药物输送系统用于有针对性的输送.
- 对这些治疗策略的当前文献的审查.
主要成果:
- 诱惑性寡氧核酸可以功能性地使NFκB无活化.
- 纳米粒子为药物输送提供了更好的稳定性和组织特异性.
- 组合疗法为慢性炎症提供了一个有希望的策略.
结论:
- 通过纳米粒子介导的诱寡氧核酸的输送是一种可行的策略.
- 这种方法可以克服当前治疗呼吸道疾病的局限性.
- 需要进一步的研究来优化这种治疗应用.
更多相关视频
10:57NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
Published on: January 12, 2020
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
相关概念视频
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Co-activators and Co-repressors
Regulation of Nuclear Protein Sorting
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
